Ted Buchan & CO Albemarle Corp Transaction History

Ted Buchan & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Sep 06, 2024	BUY	$108.73 - $146.89 $41,426 - $55,965	381 Added 7.58%	5,410 $713 Million
Q4 2023 Sep 06, 2024	SELL	$113.26 - $170.8 $17,102 - $25,790	-151 Reduced 2.92%	5,029 $727 Million
Q3 2023 Sep 06, 2024	SELL	$162.63 - $243.44 $30,411 - $45,523	-187 Reduced 3.48%	5,180 $881 Million
Q2 2023 Sep 06, 2024	BUY	$172.91 - $232.22 $928,007 - $1.25 Million	5,367 New	5,367 $1.2 Billion

928

104M

8.36M

14.3M

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $12.6B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Ted Buchan & CO, based on Form 13F filings with the SEC.

Stay updated on Ted Buchan & CO with notifications on news.